INTRODUCTION
Pseudomonas aeruginosa is a ubiquitous, opportunistic Gramnegative bacterium (Trautmann et al., 2005; Wingender & Flemming, 2011) able to form biofilms on a number of living and non-living surfaces. We have been investigating the ability of P. aeruginosa to form biofilms in the airways of individuals with cystic fibrosis (CF) (Anderson et al., 2008; Hall-Stoodley et al., 2004; Khan et al., 2010; Moreau-Marquis et al., 2009; Rau et al., 2010) . CF is a genetic disease caused by mutation of a single gene, encoding the CF transmembrane conductance regulator (CFTR) protein (Riordan et al., 1989; Warwick & Elston, 2011) . This mutation leads to impaired chloride secretion by CFTR, resulting in the formation of thick, viscous mucus plugs in the CF airways (Boucher, 2002; Campodó nico et al., 2008) . These mucus plugs predispose CF patients to colonization with numerous micro-organisms, P. aeruginosa being an important one amongst them. In an effort to control this microbial assault, CF individuals are treated with high-dose antibiotic therapies. P. aeruginosa is able to exploit the altered environment within the CF lung to become the dominant infecting agent in CF adolescents and adults (Gangell et al., 2011) . Over time, colonizing P. aeruginosa transition from a highly virulent lifestyle to a less cytotoxic, biofilm mode of growth, characterized by overproduction of the exopolysaccharide alginate. This state is often described as mucoidy (Rowen & Deretic, 2000) . Biofilm formation protects the bacteria from the host immune response (Gibson et al., 2003) and contributes to antibiotic tolerance of the bacteria within this microniche (Worlitzsch et al., 2002) . Thus, P. aeruginosa is able to persist in the CF lung for the life of the patient, and is a major factor leading to increased morbidity and mortality (Emerson et al., 2002) .
inhibit expression of the type III secretion system (T3SS) and enhance exopolysaccharide production, while RetS performs the opposite functions (Bleves et al., 2005; Goodman et al., 2004; Kuchma et al., 2005; Kulasekara et al., 2005; Laskowski et al., 2004) . Also, AlgU, and other regulators downstream of AlgU, can stimulate expression of the alginate biosynthesis pathway and inhibit T3SS expression (Gooderham & Hancock, 2009; McPhee et al., 2003; Morici et al., 2007; Yahr & Wolfgang, 2006) . These regulators dictate whether a P. aeruginosa infection is highly toxic and acute, or chronic and persistent due to biofilm formation, and their activity is likely influenced by external and internal stimuli, such as ion concentration changes and environmental stressors (Goodman et al., 2004 (Goodman et al., , 2009 Sauer et al., 2004; Tolker-Nielsen et al., 2000; Yahr & Wolfgang, 2006) . Intriguingly, chronic CF isolates often contain mutations in T3SS genes that render the system non-functional (Hoboth et al., 2009; Wu et al., 2004) , suggesting that expression of T3SS is detrimental to chronic lung infection. Early transcriptional inhibition of T3SS (before mutations occur) might enhance the ability of P. aeruginosa to establish a chronic, biofilm infection in the CF lung.
Recently, we found that P. aeruginosa virulence can be modulated by a protein called MgtE (Anderson et al., 2008 (Anderson et al., , 2010 . MgtE is a magnesium transporter expressed by a number of Gram-negative and Gram-positive bacteria, and it has been shown to influence biofilm formation of several micro-organisms (Aron et al., 1996; Kakuda & DiRita, 2006; Merino et al., 2001; Mueller et al., 2007) . Recent evidence has demonstrated that alteration of mgtE expression results in changes in P. aeruginosa cytotoxicity toward cultured airway cells (Anderson et al., 2008 (Anderson et al., , 2010 . Using a novel co-culture biofilm model system, wherein P. aeruginosa biofilms are formed directly on a CF bronchial epithelial (CFBE) cell line homozygous for the DF508 mutation (the most common mutation causing CF), increased cytotoxicity of the DmgtE P. aeruginosa biofilms toward CFBE cells was observed in comparison with wild-type (WT) P. aeruginosa (Anderson et al., 2010) . Furthermore, overexpression of mgtE resulted in decreased cytotoxicity toward the CFBE cell line compared to WT biofilms (Anderson et al., 2010) . It was discovered that the observed differences in cytotoxicity require a functional T3SS, and further analysis of possible interactions between MgtE and T3SS gene products revealed that MgtE is likely interacting either directly or indirectly with ExsA, the global T3SS transcriptional activator (Anderson et al., 2010) . These findings suggest that expression of mgtE is impacting acute virulence properties, and possibly biofilm formation, of the micro-organism.
Because of the effects of MgtE on T3SS expression, conditions that alter the regulation of mgtE transcription could thus impact P. aeruginosa biofilm formation and pathogenesis. However, the regulatory networks governing mgtE gene expression in P. aeruginosa are poorly defined. We have previously observed that treatment of P. aeruginosa biofilms with the antibiotic tobramycin, the gold-standard antibiotic for CF lung infection therapy, results in increased mgtE transcript levels (Anderson et al., 2008) . In this study, we further investigated antibioticbased regulation of mgtE gene transcription by analysing the effect of antibiotic treatments on mgtE expression and bacterial cytotoxicity. The effects of 12 different antibiotics on transcript levels of mgtE were analysed via quantitative real-time-PCR (qRT-PCR), through which we found increased levels of mgtE transcripts for most antibiotic treatments tested. Screening of a sequenced transposonmutant library, and further isogenic deletion experiments, suggested that MgtE may interact with the alginate biosynthesis protein AlgR to exact observed virulence modulatory effects. We also found that AlgR negatively regulates transcription of mgtE. These findings further elucidate the response of P. aeruginosa biofilms to antibiotics and the role of MgtE in biofilm virulence modulation in response to different environmental stimuli.
METHODS
Bacterial strains, plasmids, primers and antibiotics. The bacterial strains and plasmids used for the following studies are listed in Table 1 , and a full list of primers used in this study is presented in Table S1 (available in Microbiology Online). P. aeruginosa strain PA14 was used for all studies. Bacteria were grown overnight in LB, with appropriate concentrations of antibiotics when necessary. Antibiotics for biofilm assays were prepared according to manufacturers' specifications: tobramycin, 50 mg ml 21 in water; gentamicin, 10 mg ml 21 in water; kanamycin, 50 mg ml 21 in water; imipenem, 5 mg ml 21 in water; ceftazidime, 20 mg ml 21 in 0.1 N NaOH; azithromycin, 1 mg ml 21 in water; aztreonam, 10 mg ml 21 in water; carbenicillin, 50 mg ml 21 in water; ciprofloxacin, 10 mg ml 21 in water; nalidixic acid, 20 mg ml 21 in water; tetracycline, 15 mg ml 21 in 50 % ethanol; chloramphenicol, 30 mg ml 21 in 100 % ethanol. For MIC determination, P. aeruginosa was spread across the surface of N minimal media plates [5 mM KCl, 7.5 mM (NH 4 ) 2 SO 4 , 0.5 mM K 2 SO 4 , 1 mM KH 2 PO 4 , 0.1 M Tris/HCl, 0.1 % casamino acids, 38 mM glycerol, 1.5 % agar] (Miao et al., 2002) with the indicated amount of magnesium, and Etest strips (bioMérieux) were then placed across the surface of the agar. MIC was observed as the antibiotic concentration where the clearance zone edge crossed the strip after overnight growth at 37 uC.
Static co-culture biofilm assay. Co-culture biofilm assays were performed as we have previously described (Anderson et al., 2008; Moreau-Marquis et al., 2010) utilizing the immortalized human CFderived airway cell line CFBE41o-(CFBE), which contains a homozygous DF508 genotype (Bruscia et al., 2002; Cozens et al., 1994; Swiatecka-Urban et al., 2005) . CFBE cells were seeded in 24-well or 6-well tissue culture treated plates at a concentration of either 2610 5 cells per well or 1610 6 cells per well in 500 ml or 1.5 ml, respectively, minimal essential medium (MEM) with 10 % FBS, 50 U penicillin ml 21 and 50 mg streptomycin ml 21 (feeding medium). The cells were incubated at 37 uC at 5 % CO 2 for 7-10 days and fed every 2-3 days with fresh feeding medium, resulting in a confluent monolayer of cells. For the co-culture biofilm assay, P. aeruginosa was inoculated at an approximate concentration of 2610 7 c.f.u. ml 21 in 1.5 ml or 1.2610 7 c.f.u. ml 21 in 500 ml assay medium per well (MEM with 2 mM L-glutamine, but without FBS, streptomycin and penicillin) in 6-well or 24-well plates, respectively. These concentrations represent an approximate m.o.i. Following inoculation, the plates were incubated at 37 uC and 5 % CO 2 for 1 h. Then, the media was removed and an equal volume of fresh assay medium supplemented with 0.4 % arginine was added. Arginine promotes the formation of biofilms in this system (Anderson et al., 2008; Caiazza & O'Toole, 2004) . These plates were incubated as described for another 5-7 h, equalling a total incubation time of 6-8 h. This length of time allows mature P. aeruginosa biofilms to form on the CFBE cells in each well (Anderson et al., 2008 (Anderson et al., , 2010 . Following incubation, CFBE cell monolayer integrity was confirmed via microscopy. The c.f.u. ml 21 value calculations of biofilms were performed as previously described (Anderson et al., 2008) . Briefly, the cells in each well were washed with PBS to remove planktonic bacteria, and each well was treated with 0.1 % Triton X-100 for 15 min to lyse the epithelial cells. The lysate was then vortexed for 3 min, serially diluted and plated onto LB agar plates. The effect of each antibiotic on P. aeruginosa biofilm levels was tested in triplicate wells in three separate experiments performed on different days.
qRT-PCR analysis. For transcriptional analysis of mgtE using the static co-culture biofilm model system described above, WT P. aeruginosa strain PA14 (PA14) biofilms were formed on CFBE cells (in 6-well plates) for 7 h prior to antibiotic treatment (Table 2) . Seven hour co-culture biofilms were rinsed with PBS, and we then added fresh assay medium, supplemented with 0.4 % arginine and the indicated final concentrations of antibiotics. Because biofilm bacteria are 10-1000 times more resistant to antibiotics than planktonic bacteria (Mah & O'Toole, 2001) , we desired to add antibiotics at concentrations that were much higher than the planktonic MIC. Optimal treatment concentrations (Table 2) were chosen to reflect concentration ranges measured in sputum of CF patients treated with those antibiotics (Badia et al., 2004; Geller et al., 2002; Ilowite et al., 1987; MacGregor et al., 1986; McCoy et al., 2008; Strandvik et al., 1983; Stutman et al., 1987; Twiss et al., 2005; Wilms et al., 2008) . Antibiotic-treated cultures were incubated for 30 min at 37 uC and 5 % CO 2 . Following incubation with antibiotics, the cells were rinsed twice with 1 ml PBS, and RNA was isolated using the RNeasy Plus kit (Qiagen) by following the manufacturer's protocol with several modifications (Anderson et al., 2008) . Specifically, the cells were incubated in 600 ml (1 mg ml
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) lysozyme in Tris-EDTA buffer for 10 min. Then, the cells were lysed with 600 ml RLT lysis buffer (with b-mercaptoethanol) from the Qiagen RNeasy kit. The homogenized cells were pulled through a 20-gauge needle 10 times to shear genomic DNA and further homogenize the sample. A total of 600 ml of 100 % EtOH was mixed with the homogenized cell solution, and this mixture was added to the RNeasy columns provided with the kit. The kit protocol was followed from this point forward. To prevent DNA contamination, an on-column DNA digestion was performed according to the manufacturer's protocol. During the suggested RNA clean-up procedure, after addition of the RLT lysis buffer and before the addition of 100 % EtOH, the mixture was centrifuged through the provided genomic eliminator column. These modifications resulted in significant decrease in DNA contamination of the final RNA product. We synthesized cDNA from the isolated bacterial RNA using the Superscript III first-strand synthesis system for RT-PCR, following the protocol provided (Invitrogen) (Anderson et al., 2008) . We also chose one RNA sample to be used for an additional cDNA synthesis reaction in the absence of reverse transcriptase. This no-reverse transcriptase sample served as a negative control and confirmed the lack of DNA contamination in our original RNA samples. qRT-PCR was performed as described elsewhere (Kuchma et al., 2005) in an Applied Biosystems 7300 real-time PCR system (primers: MgtEforRTnew, MgtErevRTnew), using fbp as a normalization control transcript (primers: 5110forA, 5110revA). Samples treated with antibiotics were compared to untreated controls.
Genetic manipulations
Construction of isogenic deletion mutants. Isogenic deletion mutants were created as described previously elsewhere (Anderson et al., 2008; Shanks et al., 2006) . For deleting the algR gene, algR flanking regions were amplified by PCR with primer pairs AlgRKO # 1/AlgRKO # 2 and AlgRKO # 3/AlgRKO # 4, and the resultant PCR fragments were joined to suicide vector pMQ30 via homologous recombination in Saccharomyces cerevisiae (Shanks et al., 2006) . This deletion vector, pSC1, was then electroporated into Escherichia coli S17-1 cells and plasmid construction was confirmed by restriction digestion. The deletion vector harboured by S17-1 transformants was transferred by conjugation into target P. aeruginosa strains. Exconjugants were isolated on selective agar plates (either 50 mg gentamicin ml
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/30 mg nalidixic acid ml 21 or 250 mg carbenicillin ml 21 /30 mg nalidixic acid ml 21 ). Following the selection, the exconjugants were grown overnight in LB, and spontaneous excision of the vector was selected for by plating on 10 % sucrose/ LB plates, thus creating strain GGA225. Mutations were confirmed by PCR, using primer pair AlgRKOUP/AlgRKODOWN, and sequencing. For deletion of mgtE, we started with the plasmid pSMC233, which has a gentamicin selective cassette (Anderson et al., 2008) . However, because the transposon mutants that we used already have gentamicin resistance, we generated pSMC233-AMP, which is pSMC233 with a carbenicillin gene cassette replacing the gentamicin cassette. This was accomplished by PCR-amplifying the bla gene from pMQ70 using primer pair 30AMPfor/30AMPrev. The resultant PCR fragment was mixed with BglII-digested pSMC233, and, using the S. cerevisiae homologous recombination technique (Shanks et al., 2006) , the bla gene replaced the aacC1 gene on pSMC233, thus creating pSMC233-AMP. Deletions of mgtE were confirmed via PCR using the primers 913for and 913rev.
Transcriptional fusions with lacZ. The P exsD -lacZ reporter constructs were reported earlier (Dasgupta et al., 2006; McCaw et al., 2002) . We created algR and mgtE isogenic deletions in strains carrying the P exsD -lacZ construct (Anderson et al., 2010) as described above. To create strains with P algR -lacZ and P mgtE -lacZ transcriptional fusions, we first generated plasmid pMQ30-lacZ, which carries a promoterless lacZ gene on plasmid pMQ30, which is a suicide vector in P. aeruginosa. This was accomplished by amplifying the lacZ gene from E. coli S17-1 (Simon et al., 1983) using primers LacZfor and LacZrev. This PCR fragment was recombined with BamHI-digested pMQ30 via homologous recombination in S. cerevisiae, as above. Next, the putative promoter regions of mgtE and algR were PCRamplified using primers MgtEPromLacZfor and MgtEPromLacZrev, or AlgRPromFor and AlgRPromLacRev. These PCR fragments were recombined with BamHI-digested pMQ30-lacZ via homologous recombination in S. cerevisiae, creating plasmids pGA233 (P mgtE -lacZ) and pSC2 (P algR -lacZ). These plasmids were then electroporated into E. coli S17-1 cells and plasmid constructs were confirmed via restriction digestion. Plasmids were transferred to P. aeruginosa strains by conjugation, and exconjugants were identified via selective agar plates (LB with 50 mg gentamicin ml 21 and 30 mg nalidixic acid ml 21 ). These exconjugants contained a single crossover insertion of the plasmid at the mgtE or algR native sites (strains GGA226 and SC100 in the PA14 background, and strains SC102 and SC101 in the DalgR or DmgtE backgrounds, respectively; see Table 1 ), which positioned the promoterless lacZ gene immediately downstream of the mgtE or algR promoters. The pMQ30 plasmid contains strong transcriptional terminators downstream of the lacZ gene (Shanks et al., 2006) .
Complementation of strains. The plasmid pSMC291 contains fulllength mgtE, and it has been previously described (Anderson et al., 2010) .
Cytotoxicity assays. Cytotoxicity was assessed using the CytoTox 96 non-radioactive cytotoxicity assay (Promega), which measures lactate dehydrogenase (LDH) release from epithelial cells. LDH release indicates disturbance of the epithelial cell membrane. Confluent monolayers of CFBE cells were inoculated with 2610 7 c.f.u. bacteria ml 21 , as described above, and incubated for 1 h. Following inoculation, medium was replaced after 1 h with fresh assay medium supplemented with 0.4 % arginine, and the samples were incubated for 5 h more at 37 uC and 5 % CO 2 . Following this incubation, 350 ml supernatant was harvested and cytotoxicity was assessed according to the manufacturer's protocol (Anderson et al., 2010) . In experiments testing WT and mutant strains, bacteria were inoculated into separate wells of the same plates and analysed in exactly the same fashion. Previous experiments have demonstrated that this method results in similar bacterial growth (Anderson et al., 2008) . As a positive control for these experiments, the supplied lysis buffer was added to a separate set of wells containing CFBE monolayers that were not inoculated with bacteria, according to the manufacturer's instructions. These wells represented a maximal release of LDH, or 100 % cytotoxicity. As a negative control for these experiments, wells containing CFBE monolayers that were not inoculated with bacteria 21 , 2.7 ml b-mercaptoethanol (pH 7.0)], and then 40 ml chloroform and 10 ml 0.1 % SDS were added to each of the aliquots. This solution was vortexed for 10 s and incubated at 30 uC for 5 min. A total of 200 ml (4 mg ml 21 ) ONPG was added for 30 min at 30 uC, and then 0.5 ml 1 M Na 2 CO 3 was added to stop the reaction. Expression of lacZ was determined by the standard Miller unit equation wherein the data were normalized to the OD 600 value of the bacterial culture, as we have previously calculated (Anderson et al., 2010) . Data are representative of three independent experiments. For the b-galactosidase assay of the P mgtE -lacZ and P algR -lacZ strains, the same procedure as above was followed, except that EGTA was omitted. For testing of stresses on the P mgtE -lacZ construct, we subcultured WT P. aeruginosa from overnight cultures into 1.5 ml fresh LB in 24-well plates. Plates were incubated for 12 h, statically, and then bacteria were subjected to the indicated stresses for 30 min. in water. b-Galactosidase assays from co-culture biofilms were performed as previously described (Anderson et al., 2010) .
Twitching motility. Twitching-motility assays were performed by dipping a pipette tip into overnight cultures of the indicated bacterial strain and then stabbing the tip to the bottom of an LB agar plate, as described elsewhere (Lizewski et al., 2004) . Plates were incubated at 37 uC for 24 h, then for an additional 24 h at room temperature. Then, the agar was removed, and the plate was stained with 0.1 % crystal violet for 10 min. Twitching-zone sizes were determined by measuring three diameters for each zone and averaging. Each strain was tested in three independent experiments with three to six replicates each.
Rhamnolipid production. To detect rhamnolipids, we prepared M8 medium supplemented with 1 mM MgSO 4 , 0.2 % glucose, 0.5 % casamino acids, 0.2 % cetyltrimethylammonium bromide (CTAB), 0.0005 % methylene blue and 1.5 % agar, as described elsewhere (Caiazza et al., 2005) . Overnight culture of each strain (5 ml) was spotted on the surface of the agar and the plates were incubated at 37 uC for 24 h, then for an additional 24 h at room temperature. Secreted rhamnolipid is precipitated by the CTAB and thus forms a halo around each colony, with the diameter related to the amount of rhamnolipid produced (Siegmund & Wagner, 1991) . Diameters were measured as above for twitching. Each strain was tested in three independent experiments with three to six replicates each.
Pyocyanin production. Pyocyanin production was assessed by chloroform extraction of filter-sterilized overnight culture supernatants, as previously described (Anderson et al., 2008) . OD 376 was measured in a SpectraMax M2 spectrophotometer as a measure of relative pyocyanin levels. Each strain was tested in three independent experiments with three to four replicates each.
Statistical analysis. Statistical significance was determined via a P value ,0.05 using a two-tailed Student's t-test with Sidak adjustment for multiple comparisons. To minimize the effects of any potential non-normal distribution of our data, we numerically corrected qRT-PCR values by log 10 transformation, followed by Student's t test for significance (P,0.05). This correction resulted in reduced SD, and the overall pattern of mgtE transcript levels remained consistent with non-log 10 transformed data. Certain individual antibiotic treatments gained significance after correction, as indicated in figure legends.
RESULTS

PA14 biofilm treatment with tobramycin and other aminoglycosides
We previously found that transcriptional levels of mgtE are increased following tobramycin treatment of pre-formed biofilms of P. aeruginosa strain PA14 (PA14) at a concentration of 500 mg ml 21 (Anderson et al., 2008) . To further explore the role of tobramycin in mgtE expression, we treated pre-formed PA14 biofilms with tobramycin at concentrations of 250, 500 and 750 mg ml 21 (Table 2 ). These concentrations are within the physiologically achievable range in lungs of patients treated with this antibiotic (Badia et al., 2004; Geller et al., 2002) . qRT-PCR results show a significant increase in mgtE transcript levels following treatment with 500 and 750 mg tobramycin ml 21 (P,0.01) (Fig. 1a) . Using a transcriptional fusion of the putative mgtE promoter to lacZ, we confirmed that this increase in mgtE transcript level was accompanied by an increase in transcription (Fig. S1 ).
Tobramycin is an aminoglycoside antibiotic, and it is one of the most often used drugs for chronic P. aeruginosa infection of the CF lung because of its high activity against this micro-organism (Gibson et al., 2003) . We found that treatment of P. aeruginosa/CFBE co-culture biofilms with the tobramycin concentrations used in Fig. 1 resulted in significant decreases in the number of c.f.u. remaining on the epithelial cells, although the bacteria were not completely eradicated (Fig. S2a) .
Following these results, we analysed two other aminoglycosides, kanamycin and gentamicin, at concentration levels of 250, 500 and 750 mg ml 21 for both (Table 2 ) (Ilowite et al., 1987; Twiss et al., 2005) , and similar findings were attained (Fig. 1b, c) . qRT-PCR showed that both treatments resulted in increased transcriptional levels of mgtE at most treatment levels (P,0.01) (Fig. 1b, c) . Treatment with gentamicin resulted in significant decreases in the number of c.f.u. (P,0.05) (Fig. S2a) , but the kanamycin concentrations used were subinhibitory (P.0.05) (Fig. S2b) .
PA14 biofilm treatment with other antibiotics that inhibit protein synthesis
Aminoglycoside antibiotics inhibit protein synthesis. Considering that treatment with all three aminoglycoside antibiotics stimulated an increase in mgtE transcript levels ( Fig. 1) , we wondered whether other protein synthesisinhibiting antibiotics would have the same effect. Hence, we next tested azithromycin, chloramphenicol and tetracycline (Table 2) in our co-culture biofilm assays. Following qRT-PCR analysis, we found that these antibiotics also resulted in increased transcriptional levels of mgtE for at least one concentration treatment level (Fig. 2) . Treatment of pre-formed PA14 biofilms with azithromycin at concentrations of 10 and 30 mg ml 21 (Wilms et al., 2008) resulted in small but significant increases in mgtE transcript levels (Fig. 2a) (P,0.05, less than a twofold increase). In contrast, all chloramphenicol and tetracycline treatments resulted in striking increases in mgtE transcripts (P,0.001) (Fig. 2b, c) . These antibiotic concentrations led to slight but significantly reduced biofilm levels (P,0.05) (Fig. S2a) .
PA14 biofilm treatment with antibiotics that inhibit DNA replication
We next tested whether antibiotics from disparate classes affected mgtE transcript levels. Quinolone antibiotics inhibit DNA gyrase (topoisomerase II) thereby stalling DNA replication. We found that the quinolones ciprofloxacin and nalidixic acid both led to increases in mgtE transcript levels (P,0.001 and P,0.01, respectively) at all concentrations tested (Table 2 , Fig. 3a, b) (Stutman et al., 1987) . These treatments were subinhibitory for the coculture biofilms (P.0.05) (Fig. S2b) .
PA14 biofilm treatment with antibiotics that inhibit cell wall synthesis
We also tested several antibiotics that inhibit cell wall synthesis, including imipenem (carbapenem antibiotic class), aztreonam (monobactam class), carbenicillin (penicillin class) and ceftazidime (cephalosporin class) ( Table  2 ). Due to the role of glycopeptides as last-line-of-defence antimicrobials for infection therapy of multiresistant micro-organisms, we avoided the use of these agents. We found that the effects of cell wall inhibitory antibiotics on the transcriptional levels of mgtE were variable. qRT-PCR results following imipenem treatment demonstrated a significant increase of mgtE transcript levels at concentrations of 5 and 25 mg ml 21 (P,0.01) but not at 50 mg ml
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( Fig. 4a) (Badia et al., 2004; MacGregor et al., 1986) . However, aztreonam and carbenicillin treatment, for all three treatment levels, revealed insignificant changes in mgtE transcript levels following treatment (P.0.05) (Fig.  4b, c) (McCoy et al., 2008) . Treatment with 50 mg ceftazidime ml 21 resulted in a significant decrease in mgtE transcript levels, compared to untreated controls, while treatments with 5 and 100 mg ceftazidime ml 21 (Strandvik et al., 1983) resulted in no change (Fig. 4d) . This observed effect cannot be explained by a significant reduction in viable bacteria because all three ceftazidime treatment concentrations were subinhibitory (Fig. S2b) . Treatments with imipenem, aztreonam and carbenicillin were also found to be subinhibitory in this study (Fig. S2b) .
MICs are unaffected by changes in magnesium concentration
It is possible that increased expression of mgtE could affect antibiotic resistance. Because MgtE is a magnesium transporter, and because magnesium limitation is reported to increase expression of mgtE (McPhee et al., 2006) , we wondered whether incubation in decreased magnesium levels resulted in greater antibiotic resistance. We assayed the MIC of tobramycin, gentamicin, ciprofloxacin and imipenem, as representatives of the three modes of action of the antibiotics we tested above (protein synthesis inhibition, replication inhibition, cell wall inhibition). We found that the MIC remained the same (Table S2) , despite growth in magnesium concentrations that stimulate (0.1 mM) or repress (1 mM) mgtE transcription (McPhee et al., 2006) . Combined with our previous observation that antibiotic sensitivity was unaffected by isogenic deletion of mgtE (Anderson et al., 2008) , it seems that mgtE expression exerts only a minor role, if any, on antibiotic resistance. The antibiotic-resistance phenotype is likely multifactorial.
Response of mgtE to various stresses
Alternatively, because most of the antibiotic treatments analysed in this study resulted in increased levels of mgtE transcripts, we hypothesized that mgtE might be part of stress response pathways. To investigate this hypothesis, we monitored mgtE expression using a transcriptional fusion between the proposed mgtE promoter and lacZ (P mgtElacZ), and then measured b-galactosidase activity. Treatment with 56 M63 salts resulted in increased bgalactosidase activity, while 20 % glucose and 55 u C inhibited transcription (Table S3 ). Activity after treatment with 10 % ethanol, 100 mM KCl and 100 mM MgSO 4 remained unchanged compared to untreated controls (Table S3) .
Examining possible interactions between mgtE and known regulatory pathways
To further identify stress pathways involved in mgtE expression, we reasoned that we could identify regulators that interact or alter the activity of mgtE. We have previously found that the expression level of mgtE is related to bacterial cytotoxicity toward cultured airway epithelial cells, through inhibition of T3SS transcription (Anderson et al., 2008 (Anderson et al., , 2010 . Thus, using cytotoxicity as a readout, we screened a non-redundant PA14 transposonmutant library (Liberati et al., 2006) . Scanning through the list of genes mutated in this library, we culled 471 clones with mutations in genes with known or putative stress and/ or regulatory functions. We screened this library subset for clones with altered toxicity toward our CFBE cell line, compared to WT PA14. We identified 12 mutants with increased toxicity and 13 with decreased toxicity (Table  S4) . For our study, we assumed that clones that failed to Tetracycline (μg ml -1 ) 50 100 150 * * * Fig. 2 . Analysis of transcriptional changes in mgtE following other antibiotic treatments that inhibit protein synthesis. Significant increase in mgtE transcript levels was observed following (a) azithromycin treatment at 10 and 30 mg ml "1 concentration levels (*P,0.05), and (b) chloramphenicol and (c) tetracycline treatment at all concentration levels (*P,0.001). Transcript levels were analysed by qRT-PCR. Relative expression of mgtE was determined in relation to the normalization control transcript fbp. Data represent three independent experiments performed in triplicate (n53). All antibiotic treatments resulted in significantly increased transcript levels after log 10 correction of values (P,0.05). 3 . Analysis of transcriptional changes in mgtE following antibiotic treatments that inhibit DNA replication. Significant increase in mgtE transcript levels was observed following (a) ciprofloxacin and (b) nalidixic acid treatment at all concentration levels (*P,0.001 and *P,0.01, respectively). Transcript levels were analysed by qRT-PCR. Relative expression of mgtE was determined in relation to the normalization control transcript fbp. Data represent three independent experiments performed in triplicate (n53). All antibiotic treatments resulted in significantly increased transcript levels after log 10 correction of values (P,0.05).
Antibiotics enhance mgtE transcription show enhanced cytotoxicity upon mgtE mutation, or decreased cytotoxicity after complementation with mgtEexpression plasmid pSMC291, contained mutations in genes involved in regulating mgtE activity. Applying these conditions to the mutants identified in Table S4 , we found unexpected results from mutants in two genes: nasT and algR. The nasT mutant retained increased cytotoxicity after complementation with pSMC291, instead of the expected decrease (data not shown). Somewhat serendipitously, we deleted mgtE in the algR transposon mutant, and we found that this strain led to an unexpected decrease in cytotoxicity (Fig. 5a ). Mutation or expression of mgtE in the other mutant backgrounds resulted in negligible effects on cytotoxicity (data not shown).
AlgR is a response regulator involved in production of the biofilm polysaccharide alginate, as well as various stress response cascades. Importantly, algR is responsive to several antibiotics, including tobramycin (Anderson et al., 2008) , imipenem (Bagge et al., 2004) and numerous cell wall-active antibiotics (Wood et al., 2006) . Thus, it seemed likely that AlgR might be involved in mgtE regulation, and we pursued this connection further. We created isogenic DalgR and DmgtE/DalgR strains, and examined T3SS transcriptional activation. AlgR and MgtE both affect T3SS expression, and hence cell cytotoxicity (Anderson et al., 2010) (Lizewski et al., 2002) . T3SS transcriptional activation was monitored using strains with a P exsD -lacZ transcriptional fusion, which has been employed in numerous studies to assess T3SS transcription (Anderson et al., 2010; Dasgupta et al., 2006; McCaw et al., 2002) . We found that the DalgR mutant exhibited large, significant increases in T3SS expression compared to WT (Fig. 5b) . Importantly, we found that the DmgtE/DalgR double mutant strain exhibited significantly lower T3SS expression than all of the other strains (Fig. 5b) . These data correspond well with cytotoxicity results (Fig. 5a ).
AlgR has pleiotropic effects in P. aeruginosa (Lizewski et al., 2004; Morici et al., 2007) , and we wondered whether mgtE mutation affected additional AlgR-regulated phenotypes, and vice versa. Thus, we measured twitching motility and rhamnolipid production, which are two AlgR-mediated activities. As expected, mutation of algR resulted in negligible twitching. However, the DmgtE strain displayed WT levels of twitching. Importantly, the DmgtE/DalgR double mutant was also twitching defective (Fig. 6a) . Similarly, the DalgR and DmgtE/DalgR strains had 
05). (d)
Ceftazidime treatment resulted in a decrease of mgtE transcript levels at 50 mg ml "1 (*P,0.05). Transcript levels were analysed by qRT-PCR. Relative expression of mgtE was determined in relation to the normalization control transcript fbp. Data represent three independent experiments performed in triplicate (n53). Numerical correction of data by log 10 transformation of data resulted in a significant increase and decrease in mgtE transcript levels after treatment with 50 mg imipenem ml "1 and 5 mg ceftazidime ml "1 , respectively (P,0.05).
decreased rhamnolipid secretion, while DmgtE produced WT levels (Fig. 6b) . However, we previously found that mutation of mgtE led to decreased pyocyanin production (Anderson et al., 2008) . Mutation of algR had no effect on pyocyanin levels in culture supernatants, but the DmgtE/ DalgR strain displayed reduced amounts, similar to the DmgtE single mutant (Fig. 6c) . Taken together, these data suggest that AlgR and MgtE might not work hand-in-hand to regulate all of their reported phenotypes, but that the unique pattern of T3SS regulation and cytotoxicity we observed with the DmgtE/DalgR double mutant (Fig. 5 ) might be specific to this activity.
To begin to analyse the relationship between MgtE and AlgR, we investigated whether mutation of one gene led to altered expression of the other. Toward that end, we generated lacZ transcriptional fusions to the putative promoters of mgtE and algR, as described in Methods, and measured b-galactosidase production in WT and mutant strains. In this manner, we found little difference in algR promoter activity between WT and DmgtE strains (Fig. 7a) . However, transcription from the mgtE promoter was greatly enhanced by mutation of algR compared to the WT strain (Fig. 7b) .
DISCUSSION
MgtE, a magnesium transport protein, has been identified as a virulence modulatory protein in P. aeruginosa (Anderson et al., 2008 (Anderson et al., , 2010 , and a virulence and biofilm modulatory protein in several other bacteria (Aron et al., 1996; Kakuda & DiRita, 2006; Merino et al., 2001; Mueller et al., 2007) . However, the regulation of mgtE and the environmental signals that influence mgtE transcription (and thus affect downstream virulence pathways) are poorly understood. In previous studies, we found that mgtE could affect bacterial cytotoxicity through modulation of T3SS (Anderson et al., 2010) , and that tobramycin treatment resulted in a significant increase in mgtE transcript levels (Anderson et al., 2008) . Importantly, isogenic deletion of mgtE resulted in WT levels of antibiotic sensitivity (Anderson et al., 2008) , suggesting that mgtE induction might play only a minor role in antibiotic resistance. In accordance with these previous findings, we also observed that incubation in decreased levels of magnesium, which can stimulate mgtE transcription, has little effect on MIC (Table S2) .
Instead, we hypothesized that antibiotics act as signals that induce mgtE transcription, as part of an effort to downregulate production of factors associated with acute infections (e.g. T3SS) during biofilm development. To investigate this issue, we analysed mgtE transcript levels in co-culture biofilms treated with 12 different antibiotics, and we found a general mgtE transcript increase (Figs 1-4) , with the exception of aztreonam, carbenicillin and ceftazidime treatments ( Fig. 4b-d) . Importantly, these results were not altered by changing bacterial levels as a product of antibiotic treatment. Most treatments resulted in insignificant changes in viable bacterial levels (kanamycin, ciprofloxacin, nalidixic acid, imipenem, aztreonam, carbenicillin, ceftazidime; Fig. S2b) . For the treatments that did produce significant decreases in bacterial c.f.u. levels (tobramycin, gentamicin, azithromycin, chloramphenicol, tetracycline; Fig. S2a ), mgtE transcript levels were significantly increased (Figs 1-3) . Additionally, total RNA levels were normalized prior to analysis, and we used an unchanging internal control transcript (fbp) (Anderson et al., 2010) in our qRT-PCR experiments. Thus, it is likely that changes in mgtE transcription were unrelated to c.f.u. changes.
Antibiotic interaction with P. aeruginosa biofilms is rather complex. Studies have demonstrated that different antibiotics can have diverse effects on biofilm bacteria, such as biofilm enhancement, inhibition of quorum sensing, alterations in biofilm architecture, and upregulation of virulence factors and modulators (Hoffman et al., 2005; Kobayashi, 1995; Kuchma et al., 2005; Linares et al., 2006; Skindersoe et al., 2008) . Tobramycin and ciprofloxacin treatment at subinhibitory levels induce biofilm formation (Hoffman et al., 2005; Linares et al., 2006) . However, treatment with subinhibitory levels of carbenicillin did not increase biofilm formation (Tuomanen et al., 1986) . Azithromycin has been shown to inhibit the alginate biosynthesis pathway and quorum sensing, both of which are important for biofilm development. Furthermore, azithromycin treatment repressed T3SS at concentrations below 8 mg ml 21 (Kobayashi, 1995; Skindersoe et al., 2008) . Interestingly, following azithromycin treatment of biofilms in our study, mgtE transcription did not significantly increase at 5 mg ml 21 , but did significantly increase at 10 and 30 mg ml 21 (Fig. 2) . Ciprofloxacin and ceftazidime, tested at concentrations much lower than analysed in our study, exhibit strong quorum sensing inhibitory effects (Skindersoe et al., 2008) , although the specific set of genes with which the antibiotics interact to cause this effect varies. Imipenem treatment at subinhibitory concentration (1 mg ml
21
) causes increased production of the exopolysaccharide alginate by inducing increased expression of many important regulatory proteins in the alginate biosynthesis pathway, including AlgR (Bagge et al., 2004) . Thus, it is possible that our antibiotic treatments of coculture biofilms alter quorum sensing and alginate levels, although additional studies are needed to test this hypothesis and elucidate the underlying molecular mechanisms.
AlgR is a regulatory protein that functions in many different pathways, most notably the alginate biosynthesis pathway. Induction of this pathway results in a mucoid P. aeruginosa phenotype, due to production of copious amounts of alginate. The mucoidy phenotype is employed during chronic infection of the CF airway and enhances biofilm formation. AlgR is part of the two component regulatory system AlgR-AlgZ pathway, which interacts with AlgU (Yu et al., 1997) , the sigma factor that activates many genes essential for induction of the alginate pathway, including algR (Mathee et al., 1997) . Furthermore, algR is an important gene for P. aeruginosa pathogenesis, as an algR mutant is less virulent than a WT strain in an acute septicaemia mouse model of infection (Lizewski et al., 2002) . AlgR is also required for twitching motility, which is associated with increased virulence (Whitchurch et al., 1996) . This evidence, as well as proteomic analysis of an algR mutant (Lizewski et al., 2002) , suggests that AlgR is a global regulator impacting the expression of many different genes, including the T3SS genes. When AlgR is mutated, an increased expression of certain T3SS genes, such as exsA and exoS, is observed. ExsA is the master regulator for the T3SS in P. aeruginosa (Wu et al., 2004) , and prior findings suggest that MgtE may be directly or indirectly interacting with this protein to inhibit T3SS (Anderson et al., 2008) . Indeed, increased expression of mgtE leads to decreased T3SS production and lowered cytotoxicity (Anderson et al., 2010) . These results imply important but complex interactions of AlgR with other virulence pathways in P. aeruginosa. Furthermore, our findings support a possible interaction between algR and mgtE (Fig. 5 ). This result is further corroborated by our finding that deletion of algR in the DmgtE strain led to decreased transcription of exsD (Fig. 5) . Also, our results suggest that algR has negative regulatory effects on mgtE transcription (Fig. 7) . Altogether, this implies that there is a peculiar cross-talk between algR and mgtE in regulating the T3SS, and this effect seems to be specific to T3SS (Fig. 6 ). Because reduction in T3SS is an important component of P. aeruginosa biofilms in the CF lung, these data support the hypothesis that mgtE can influence the biofilm phenotype in response to CF-relevant signals. We speculate that MgtE and AlgR both inhibit the function of a T3SS repressor, either separately or in concert. In this scheme, mutation of either mgtE or algR is compensated by the presence of the other, but when both are mutated, high-level activity of the repressor prevents T3SS transcription and cytotoxicity. However, it is also possible that MgtE and AlgR could be acting independently on T3SS. Further studies are needed to fully characterize the relationship between these two proteins, and whether MgtE regulation of T3SS is mediated by the observed mgtE regulation by AlgR (Fig. 7) .
Through our studies, we have clearly demonstrated that numerous antibiotics can enhance mgtE transcription, possibly as the result of activation of stress responses. Indeed, AlgR is regulated by the s E homologue AlgU, which responds to heat shock, among other envelope stresses. Thus, inhibition of mgtE transcription at 55 u C (Table S3 ) could be the result of repression of elevated levels of AlgR under these conditions. Additionally, it is possible that mgtE is activated by the stringent response (van Delden et al., 2001) , as evidenced by increased mgtE transcription in the nutrient-limited M63 medium (without carbon or amino acids sources) (Table S2) . Enhanced mgtE expression could result in biofilm phenotype changes by decreasing T3SS (Anderson et al., 2010) and possibly interacting with other known virulence pathways. A greater understanding of mgtE regulation could lead to novel methods of inhibiting biofilm formation and bacterial toxicity. Our data suggest that AlgR might act as a link between external signals like antibiotics and mgtE transcriptional responses. As we dissect the complex relationship between mgtE, biofilm formation and toxicity, we can devise novel methods for treatment of this recalcitrant microbe. 
